Selective C(sp3)-H Oxidations and Functionalizations with Tunable Metal Catalysts for Synthesis

使用可调金属催化剂进行选择性 C(sp3)-H 氧化和官能化合成

• 批准号: 10593944
• 负责人: Maria White
• 金额: $ 54.95万
• 依托单位: UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-05-01 至 2027-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10593944
• 关键词: 3-Dimensional; Alcohols; Alkylation; Amination; Area; Biological; Biological Process; Carbon; Chemistry; Communities; Complex; Coupling; Electronics; Foundations; Hydrocarbons; Hydrogen Bonding; Individual; Industrialization; Iron; Ligands; Manganese; Metals; Natural Products; Outcome; Palladium; Pharmaceutical Preparations; Process; Property; Reaction; Site; Sulfoxide; Technology; Therapeutic; Work; base; catalyst; chemical synthesis; commercialization; drug candidate; drug discovery; empowerment; functional group; innovation; invention; metal complex; novel; oxidation; phthalocyanine; physical property; programs; scaffold; small molecule

PI, White, M.C.    R35 GM 122525    1  Project Summary 2  3  The atomistic change of C(sp3)–H to C(sp3)–O, –N, or –C can profoundly impact the biological function and 4  physical properties of small molecules. Traditionally, introducing these functionalities relies on functional group 5  transformations from pre-oxidized carbon-heteroatom precursors. This approach limits the direct installation of new 6  functionality into complex molecules, often necessitating de novo synthesis that is impractical for rapid exploration of 7  biological function. Our proposal aims to provide selective C(sp3)–H functionalization reactions that install O, N and 8  C in the hydrocarbon scaffold of complex molecules. This will enable late-stage functionalizations that expedite drug 9  discovery processes, streamline total syntheses, and empower exploration of natural products as drug candidates. 10  Our group has shown that C(sp3)–H bonds in complex molecules can be distinguished based on their 11  electronic, steric, and stereoelectronic properties, resulting in a paradigm shift within the chemistry community that 12  prior to 2007 viewed aliphatic C–H bonds as preparatively indistinguishable. To do this, we have discovered and 13  commercialized iron and manganese PDP-based catalysts for C(sp3)–H oxidations; palladium(II)/sulfoxide catalysts 14  for allylic C–H functionalization; and manganese phthalocyanine catalysts for both intra- and intermolecular C(sp3)– 15  H aminations. These catalysts proceed with excellent levels of reactivity and selectivity in complex molecule settings, 16  without the need for directing groups. The late-stage functionalization approach that has emerged from this work has 17  been utilized in both industrial and academic settings. Building on this considerable foundation, we will undertake 18  major challenges required to broaden the application of late-stage functionalization in chemical synthesis and drug 19  discovery. We will innovate new base-metal complexes for aliphatic C–H oxidations that increase chemoselectivity 20  for tolerance of π-functionality and unprotected alcohols, as well as explore catalyst chiral recognition through non- 21  bonding interactions. These advances will make possible new reactions such as oxidative alkylations and catalyst- 22  controlled asymmetric induction and site-divergence. We will develop new base-metal complexes for intermolecular 23  C–H aminations and alkylations with unprecedented selectivities, and discover new ligand types amenable to 24  asymmetric induction. New palladium(II)/sulfoxide catalysts will be invented with an emphasis on introducing 25  functionality in complex settings. Cross-coupling reactions will be developed where O and N are introduced as part of 26  complex fragments. Additionally, asymmetric C–H functionalizations that feature catalyst-controlled 27  diastereoselectivities in substrates with pre-existing stereogenic centers will be advanced. Collectively, this program 28  will change the way synthetic chemists make and diversify complex molecules in pursuit of therapeutics, metabolites, 29  and biological probes.

PI, White, M.C.    R35 GM 122525    1  Project Summary 2  3  The atomistic change of C(sp3)–H to C(sp3)–O, –N, or –C can profoundly impact the biological function and 4  physical properties of small molecules. Traditionally, introducing these functionalities relies on functional group 5  transformations from pre-oxidized carbon-heteroatom precursors. This approach limits the direct installation of new 6  functionality into complex molecules, often necessitating de novo synthesis that is impractical for rapid exploration of 7  biological function. Our proposal aims to provide selective C(sp3)–H functionalization reactions that install O, N and 8  C in the hydrocarbon scaffold of complex molecules. This will enable late-stage functionalizations that expedite drug 9  discovery processes, streamline total syntheses, and empower exploration of natural products as drug candidates. 10  Our group has shown that C(sp3)–H bonds in complex molecules can be distinguished based on their 11  electronic, steric, and stereoelectronic properties, resulting in a paradigm shift within the chemistry community that 12  prior to 2007 viewed aliphatic C–H bonds as preparatively indistinguishable. To do this, we have discovered and 13  commercialized iron and manganese PDP-based catalysts for C(sp3)–H oxidations; palladium(II)/sulfoxide catalysts 14  for allylic C–H functionalization; and manganese phthalocyanine catalysts for both intra- and intermolecular C(sp3)– 15  H aminations. These catalysts proceed with excellent levels of reactivity and selectivity in complex molecule settings, 16  without the need for directing groups. The late-stage functionalization approach that has emerged from this work has 17  been utilized in both industrial and academic settings. Building on this considerable foundation, we will undertake 18  major challenges required to broaden the application of late-stage functionalization in chemical synthesis and drug 19  discovery. We will innovate new base-metal complexes for aliphatic C–H oxidations that increase chemoselectivity 20  for tolerance of π-functionality and unprotected alcohols, as well as explore catalyst chiral recognition through non- 21  bonding interactions. These advances will make possible new reactions such as oxidative alkylations and catalyst- 22  controlled asymmetric induction and site-divergence. We will develop new base-metal complexes for intermolecular 23  C–H aminations and alkylations with unprecedented selectivities, and discover new ligand types amenable to 24  asymmetric induction. New palladium(II)/sulfoxide catalysts will be invented with an emphasis on introducing 25  functionality in complex settings. Cross-coupling reactions will be developed where O and N are introduced as part of 26  complex fragments. Additionally, asymmetric C–H functionalizations that feature catalyst-controlled 27  diastereoselectivities in substrates with pre-existing stereogenic centers will be advanced. Collectively, this program 28  will change the way synthetic chemists make and diversify complex molecules in pursuit of therapeutics, metabolites, 29  and biological probes.